Misra Usha Kant, Kalita Jayantee, Nair Pradeep P
Department of Neurology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, India.
Am J Med. 2008 Jul;121(7):618-23. doi: 10.1016/j.amjmed.2008.02.012.
There is a paucity of comprehensive study in status epilepticus in central nervous system infections. This observational study evaluated the response to antiepileptic drugs in patients with status epilepticus and central nervous system infection.
The study took place at a tertiary care teaching hospital in India. A total of 37 of 93 adult patients (39.8%) with status epilepticus had central nervous system infection, and they underwent clinical evaluation, including status type and duration. Magnetic resonance imaging and cerebrospinal fluid analyses were performed. Patients were categorized into encephalitis, meningitis, and granuloma groups. The response to antiepileptic drugs was noted, and the status was considered refractory if seizures continued after the second antiepileptic drug. Refractory status epilepticus and mortality were correlated with the type of infection and various clinical and magnetic resonance imaging findings.
The median age of the patients was 37 years (16-78 years), and 17 patients were female; 35 patients had convulsive status epilepticus, and 2 patients had nonconvulsive status epilepticus. Twenty patients had encephalitis (Japanese 4, herpes simplex 3, nonspecific 12), including 1 patient with malaria, 9 patients with meningitis (tubercular 5, pyogenic 3, fungal 1), and 7 patients with granuloma (tubercular 5, neurocysticercosis 2). The mean duration of status epilepticus was 19.6 hours (0.25-72 hours). Magnetic resonance imaging results were abnormal in 66.7% of patients. In 67.6% of patients, status epilepticus was controlled after the first antiepileptic drug. Some 24.3% of patients were refractory to the second antiepileptic drug, and 10.8% of patients did not respond to the third antiepileptic drug. Patients with encephalitis had an insignificantly poor response. Eleven patients (29.7%) died, and mortality was higher in patients with refractory status epilepticus.
Of patients with status epilepticus and central nervous system infection, 24.3% had a refractory status that was associated with a high mortality. Their response to an antiepileptic drug in encephalitis was insignificantly poorer.
中枢神经系统感染所致癫痫持续状态的综合研究较少。本观察性研究评估了癫痫持续状态合并中枢神经系统感染患者对抗癫痫药物的反应。
该研究在印度一家三级护理教学医院进行。93例癫痫持续状态成年患者中,共有37例(39.8%)合并中枢神经系统感染,他们接受了临床评估,包括癫痫类型和持续时间。进行了磁共振成像和脑脊液分析。患者被分为脑炎组、脑膜炎组和肉芽肿组。记录对抗癫痫药物的反应,如果在使用第二种抗癫痫药物后仍有癫痫发作,则该状态被视为难治性。难治性癫痫持续状态和死亡率与感染类型以及各种临床和磁共振成像结果相关。
患者的中位年龄为37岁(16 - 78岁),17例为女性;35例为惊厥性癫痫持续状态,2例为非惊厥性癫痫持续状态。20例患有脑炎(日本脑炎4例、单纯疱疹病毒性脑炎3例、非特异性脑炎12例),其中1例患有疟疾,9例患有脑膜炎(结核性脑膜炎5例、化脓性脑膜炎3例、真菌性脑膜炎1例),7例患有肉芽肿(结核性肉芽肿5例、神经囊尾蚴病性肉芽肿2例)。癫痫持续状态的平均持续时间为19.6小时(0.25 - 72小时)。66.7%的患者磁共振成像结果异常。67.6%的患者在使用第一种抗癫痫药物后癫痫持续状态得到控制。约24.3%的患者对第二种抗癫痫药物难治,10.8%的患者对第三种抗癫痫药物无反应。脑炎患者的反应略差,但无统计学意义。11例患者(29.7%)死亡,难治性癫痫持续状态患者的死亡率更高。
癫痫持续状态合并中枢神经系统感染的患者中,24.3%为难治性状态,且与高死亡率相关。他们在脑炎中对抗癫痫药物的反应略差,但无统计学意义。